$0.200
+0 (+0%)
At Close: Oct 10, 2025
All You Need to Know About UNITY Biotechnology, Inc. (UBX) Rating Upgrade to Strong Buy
01:32pm, Monday, 10'th Oct 2022
UNITY Biotechnology, Inc. (UBX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near ter
The Three Best Anti-Aging Stocks to Buy in September
07:00am, Monday, 19'th Sep 2022
Anti-aging stocks have not proven immune to poor market conditions that have plagued the broader biotech industry. The biotech industry remains hampered by the same bleak economic conditions as those
UNITY Biotechnology to Participate in Upcoming Investor Conferences
08:00am, Wednesday, 31'st Aug 2022
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (Nasdaq: UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, tod
Bears are Losing Control Over UNITY Biotechnology, Inc. (UBX), Here's Why It's a 'Buy' Now
11:17am, Tuesday, 30'th Aug 2022
UNITY Biotechnology, Inc. (UBX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agree
Hot Penny Stocks to Add to Your Watchlist Right Now
06:00am, Monday, 15'th Aug 2022
Here's what you need to know about trading penny stocks on August 15th The post Hot Penny Stocks to Add to Your Watchlist Right Now appeared first on Penny Stocks to Buy, Picks, News and Information |
Why Is Unity Biotechnology (UBX) Stock Up 71% Today?
11:05am, Friday, 12'th Aug 2022
Source: everything possible / Shutterstock.com Unity Biotechnology (NASDAQ: UBX ) stock is surging higher on Friday following the release of its earnings report for the second quarter of 2022. That re
Unity Biotechnology (UBX) Stock: Why It Skyrocketed Over 120% Today
09:16am, Friday, 12'th Aug 2022
The stock price of Unity Biotechnology (UBX) skyrocketed over 120% pre-market today. This is why.
UNITY Biotechnology to Present Clinical Data at the American Society of Retina Specialists (ASRS) 40th Annual Scientific Meeting
04:00pm, Tuesday, 12'th Jul 2022
SOUTH SAN FRANCISCO, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases
UNITY Biotechnology Announces Appointment of Accomplished Finance and Operations Executive Michael Samar to the Board of Directors
12:00pm, Thursday, 26'th May 2022 GlobeNewswire Inc.
SAN FRANCISCO, May 26, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, to
Unity Biotechnology GAAP EPS of -$0.18 beats by $0.18, revenue of $4.78M
01:04pm, Tuesday, 15'th Mar 2022 Seeking Alpha
Unity Biotechnology press release (UBX): Q4 GAAP EPS of -$0.18 beats by $0.18.Revenue of $4.78M.Cash, cash equivalents and marketable securities totaled $90.1 million as of December…
95 Biggest Movers From Friday
08:52am, Monday, 14'th Mar 2022 Benzinga
Gainers Marygold Companies (NYSE: MGLD ) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday. TeraWulf Inc. (NASDAQ: WULF ) gained 49.3% to close at $9.51. Guardforce AI Co., Limited (NASDAQ: GFAI ) jumped 45% to settle at $0.7796 after the company agreed to acquire Shenzhen Keweien and Guangzhou Kewei for $10 million. Clearside Biomedical, Inc. (NASDAQ: CLSD ) rose 42.6% to settle at $1.9250 after the company reported better-than-expected Q4 results. Excellon Resources Inc. (NYSE: EXN ) rose 40.8% to close at $1.38 after jumping around 13% on Thursday. Solid Biosciences Inc. (NASDAQ: SLDB ) jumped 37.4% to settle at $1.06. Altamira Therapeutics Ltd. (NASDAQ: CYTO ) shares gained 36.7% to settle at $0.9449. Altamira Therapeutics reported in vitro efficacy data for bentrio nasal spray in protecting against Sars-CoV-2 omicron variant. 4D pharma plc (NASDAQ: LBPS ) shares surged 35.3% to settle at $3.99. Kala Pharmaceuticals, Inc. (NASDAQ: KALA ) gained 33.1% to close at $1.69.
Ascentage Pharma to Present Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022
11:47pm, Tuesday, 08'th Mar 2022 Kwhen FinanceUnity Biotechnology (UBX) Investor Presentation - Slideshow
09:59pm, Friday, 04'th Mar 2022 Seeking AlphaUNITY posts 24-week data from Phase 1 trial for UBX1325 in vascular eye diseases
05:12pm, Monday, 14'th Feb 2022 Seeking Alpha
UNITY Biotechnology <> announced 24-week data from its Phase 1 study for UBX1325 in patients with diabetic macular edema ((DME)) and wet age-related macular degeneration (wet…
UNITY Biotechnology Announces Additional Data from Phase 1 Study of UBX1325 in Advanced Vascular Eye Disease
01:00pm, Monday, 14'th Feb 2022 GlobeNewswire Inc.
24-week UBX1325 Phase 1 data presented at Angiogenesis, Exudation, and Degeneration 2022 Conference
Sign In
Buy UBX